1. Home
  2. Programs
  3. Medical Industry Feature

Navigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data

Details
Recommended

Overview

ReachMD Healthcare Image
RestartResume

Recent research examined results from MCED testing and subsequent diagnostic workup. Here’s how it can impact patient management.

  • Sponsored by

  • Overview

    With an urgent need to screen for cancer, clinical trials have shown that the multi-cancer early detection (MCED) test Galleri® can screen for more than 50 distinct cancer types in adults 50 and over and predict its origin. Questions have remained regarding the risk of cancer for those patients with a CSD MCED result, followed by a diagnostic evaluation that did not result in a cancer diagnosis and a second MCED test. Recent research was conducted to help address this gap, and now, Dr. Eric Klein joins Dr. Charles Turck to share the real-world outcomes following a Galleri MCED retest. Dr. Klein is a distinguished scientist at Grail and one of the elite investigators on the clinical studies that led to the development of the Galleri MCED test.

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free